The distribution of the 750 microgram Teriparatide injection in the Australian market is currently restricted due to this specialist nature and a criteria for administration. While uptake figures are not readily disclosed, the treatment is mainly provided through specialist physicians and private hospitals . Patients eligible for the therapy typica